Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases (2019 - 2025)

Historic Operating Leases for Veracyte (VCYT) over the last 7 years, with Q3 2025 value amounting to $40.5 million.

  • Veracyte's Operating Leases rose 10540.77% to $40.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 10540.77%. This contributed to the annual value of $43.2 million for FY2024, which is 47457.81% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Operating Leases is $40.5 million, which was up 10540.77% from $50.6 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Operating Leases ranged from a high of $50.6 million in Q2 2025 and a low of $7.5 million during Q4 2023
  • Its 5-year average for Operating Leases is $21.8 million, with a median of $16.5 million in 2022.
  • As far as peak fluctuations go, Veracyte's Operating Leases plummeted by 2932.95% in 2023, and later soared by 47457.81% in 2024.
  • Over the past 5 years, Veracyte's Operating Leases (Quarter) stood at $14.1 million in 2021, then decreased by 24.46% to $10.6 million in 2022, then decreased by 29.33% to $7.5 million in 2023, then skyrocketed by 474.58% to $43.2 million in 2024, then decreased by 6.44% to $40.5 million in 2025.
  • Its Operating Leases was $40.5 million in Q3 2025, compared to $50.6 million in Q2 2025 and $50.5 million in Q1 2025.